The prevalence of Parkinson disease was projected to be 267 cases per 100,000 in 2050, representing a 76% increase from 2021. (HealthDay News) — The prevalence of Parkinson disease is projected to ...
Initiation of dosing in our Phase 1b clinical trial represents an important step in the clinical development of GT-02287 and in Gain’s mission to deliver a disease-modifying therapy to people with ...
Interim Analysis Expected End of 2Q 2025 BETHESDA, MD / ACCESS Newswire / March 14, 2025 / Gain Therapeutics, Inc. (Nasdaq:GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company lead ...
WEHI researchers have made a huge leap forward in the fight against Parkinson's disease, solving a decades-long mystery that paves the way for development of new drugs to treat the condition.
Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter with an ALS advocate, Ben-Noon assembled a team of top scientists to develop ...
A recent study predicts that by 2050, 25.2 million people worldwide will be living with Parkinson’s disease—more than double ...
Philip Lewis Pittman Philip Pittman was born on 3/24/1937 in Centerville, Iowa. He passed away in Albuquerque, New Mexico on 2/23/2025 due to advanced symptoms of Parkinson's Disease. Phil spent most ...
Parkinson's disease cases are projected to double globally by 2050, reaching 25 million individuals, according to a recent ...
Hospice use varies depending on whether a person has Parkinson’s disease, Lewy body dementia or Alzheimer’s disease and those with Parkinson’s may have more unmet needs, a new study finds.
Every Tuesday morning, a group of people from their late 60s to their early 80s gather at Spire to climb. They all have one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results